跳至主要内容
临床试验/NCT04374058
NCT04374058Unknown不适用

Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease

Dialisis Madariaga1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年3月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Mortality

研究概览

简要总结

Facing the unusual situation imposed by the coronavirus disease, the aim of this study is to evaluate the risk and effects of less frequent hemodialysis on prevalent patients

详细描述

The novel coronavirus disease (COVID-19), also known as COVID-19 (and SARS-Cov2) by the World Health Organization, is a rapidly evolving pandemic. The outbreak is expected to infect a large portion of the world population, and a case fatality rate of 1-3% represents a significant mortality and healthcare burden. In common with other viral diseases, mortality is higher in elderly patients with high comorbidity.

The impressive figures of transmission in different communities underline the need for reorganization of efforts to limit contagion, particularly in crowded settings. Hemodialysis centres represents a specific setting in which many patients are repeatedly treated in the same area at the same time.

Dialysis patients constitute a susceptible population because of their older age, high comorbidity burden and their less efficient immune system. Therefore, they are more prone to develop severe infectious diseases than the general population.. Moreover, if infected, the requirements of specialized resources and staff is further complicated by requirements for isolation, control and prevention, putting healthcare systems under additional strain. Therefore, all measures to slow and to control unmanageably high incidence rates must be taken very seriously.

The routine treatment usually requires three dialysis sessions per week Further, some patients must travel long distances to the dialysis centre. One option to reduce the higher risk of these patients is to reduce the frequency of dialysis sessions.However, the potential benefits of reduced risk may be associated with higher interdialytic weight gain and inadequate dialysis, Two factors that increase the risk of mortality. Furthermore, the impact of reduced frequency on Anemia and Nutrition have not been extensively studied.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • More than 30 days of Chronic ambulatory in-center hemodialysis

排除标准

  • More than three sessions a week
  • amputated lower limbs

结局指标

主要结局

Mortality

时间窗: From date of beginning of the study until the date of death assessed up to 52 weeks

Time to all-cause and cardiovascular death

次要结局

  • Hospitalization(From date of beginning of the study until the date of first hospitalization assessed up to 52 weeks)
  • Anemia, Nutrition, Adequation of dialysis, total ultrafiltration, ultrafiltration rate,(From date of beginning of the study assessed up to 52 weeks)
  • Vascular Access(From date of beginning of the study until the date of first intervention assessed up to 52 weeks)

研究者

发起方
Dialisis Madariaga
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Less Frequency Hemodialysis and COVID-19 | 临床试验